Locoregional infusion of HER2-specific CAR T cells in children and young adults with recurrent or refractory CNS tumors: an interim analysis
Nicholas A. Vitanza, Adam Johnson, Ashley Wilson, Christopher Brown, Jason K. Yokoyama, Annette Künkele, Cindy A. Chang, Stephanie Rawlings-Rhea, Wenjun Huang, Kristy Seidel, Catherine M. Albert, Navin Pinto, Juliane Gust, Laura S. Finn, Jeffrey G. Ojemann, Jason N. Wright, Rimas J. Orentas, Michael Baldwin, Rebecca Gardner, Michael C. Jensen, Julie R. Park
Topics & Concepts
MedicineTolerabilityChimeric antigen receptorDosingMedulloblastomaImmune systemOncologyInterim analysisToxicityClinical trialInternal medicineImmunotherapyAdverse effectImmunologyPathologyCAR-T cell therapy researchNanowire Synthesis and ApplicationsAdvancements in Semiconductor Devices and Circuit Design